Literature DB >> 5492043

Hepatic effect of sulfonylureas.

A Marshall, R L Gingerich, P H Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5492043     DOI: 10.1016/0026-0495(70)90028-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  11 in total

1.  [Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment].

Authors:  F H Schmidt; J Klujko; H F Kühnle; J Reiter
Journal:  Klin Wochenschr       Date:  1986-10-15

2.  Extrapancreatic insulin effect of glibenclamide.

Authors:  H Mulder; W Schopman; A J van der Lely
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Sulfonylureas: a new look at old therapy.

Authors:  Peter M Thulé; Guillermo Umpierrez
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 4.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.

Authors:  I Lundquist
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

6.  Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.

Authors:  P Heine; H Kewitz; U Schnapperelle
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

7.  Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.

Authors:  A A Connacher; A H el Debani; T E Isles; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Influence of sulfonylureas on the secretion, disposal and effect of insulin.

Authors:  L O Almér; E Johansson; A Melander; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.

Authors:  A J Scheen; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  The metabolism of proinsulin and insulin by the liver.

Authors:  A H Rubenstein; L A Pottenger; M Mako; G S Getz; D F Steiner
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.